| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.HRTHM.2011.07.025 |
| P698 | PubMed publication ID | 21798230 |
| P50 | author | Hugh Calkins | Q67190496 |
| P2093 | author name string | David Edwards | |
| Alan Cheng | |||
| Joseph E Marine | |||
| Saman Nazarian | |||
| Charles A Henrikson | |||
| David D Spragg | |||
| Sunil Sinha | |||
| Ronald Berger | |||
| Karuna Chilukuri | |||
| Aditya Bhonsale | |||
| Hana Hoyt | |||
| Fawaz Alhumaid | |||
| Matthew Needleman | |||
| Ashul Govil | |||
| P433 | issue | 12 | |
| P921 | main subject | catheter ablation | Q436572 |
| Atrial Fibrillation | Q815819 | ||
| P304 | page(s) | 1869-1874 | |
| P577 | publication date | 2011-07-26 | |
| P1433 | published in | Heart Rhythm | Q2058605 |
| P1476 | title | Complications arising from catheter ablation of atrial fibrillation: temporal trends and predictors. | |
| P478 | volume | 8 |
| Q37989837 | 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design |
| Q55263071 | 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design |
| Q27341873 | 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society |
| Q26782673 | 2015 ACC/AHA/HRS Advanced Training Statement on Clinical Cardiac Electrophysiology (A Revision of the ACC/AHA 2006 Update of the Clinical Competence Statement on Invasive Electrophysiology Studies, Catheter Ablation, and Cardioversion) |
| Q45059153 | 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation |
| Q46658026 | 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation |
| Q42172443 | 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: Executive summary. |
| Q42373398 | 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: executive summary |
| Q45069696 | 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: Executive summary |
| Q46192667 | Ablation for atrial fibrillation: what are acceptable levels of experience, efficacy, and complications? |
| Q86497135 | Ablation of atrial fibrillation |
| Q38069565 | Anesthesia for electrophysiology studies and catheter ablations |
| Q94031094 | Atrial fibrillation |
| Q30241862 | Atrial fibrillation in women: treatment |
| Q37495821 | Catheter Ablation of Atrial Fibrillation in Females |
| Q38790580 | Catheter Ablation of Atrial Fibrillation to Maintain Sinus Rhythm |
| Q53614389 | Catheter ablation for asymptomatic atrial fibrillation? |
| Q38055828 | Catheter ablation of atrial arrhythmias: state of the art. |
| Q43737869 | Catheter ablation of atrial fibrillation in patients at low thrombo-embolic risk: efficacy and safety of a simplified periprocedural anticoagulation strategy |
| Q86414206 | Catheter ablation of atrial fibrillation in the young: insights from the German Ablation Registry |
| Q38258667 | Catheter ablation of persistent atrial fibrillation |
| Q37495638 | Collateral Damage During Ablation of Atrial Fibrillation - Lessons Learnt in the Past Decade |
| Q37496170 | Collateral Damage from Catheter Ablation of Atrial Fibrillation Lessons Learnt in the Past Decade |
| Q28073175 | Comparison of Phrenic Nerve Injury during Atrial Fibrillation Ablation between Different Modalities, Pathophysiology and Management |
| Q47100732 | Comparison of health-related quality of life in patients with atrial fibrillation treated with catheter ablation or antiarrhythmic drug therapy: a systematic review and meta-analysis protocol |
| Q26850213 | Complications of catheter ablation of atrial fibrillation: a systematic review |
| Q47614939 | Complications of pulmonary vein isolation in atrial fibrillation: predictors and comparison between four different ablation techniques: Results from the MIddelheim PVI-registry |
| Q44690504 | Dabigatran versus warfarin anticoagulation before and after catheter ablation for the treatment of atrial fibrillation |
| Q42380254 | Distinguishing Tachycardia Mediated From Structural Cardiomyopathy: Association of Late Gadolinium Enhancement With Recovery of Ventricular Systolic Function Following Atrial Fibrillation Ablation |
| Q92385031 | Effect of Catheter Ablation vs Antiarrhythmic Medication on Quality of Life in Patients With Atrial Fibrillation: The CAPTAF Randomized Clinical Trial |
| Q48285999 | Effect of a photosensitization reaction performed during the first 3 min after exposure of rat myocardial cells to talaporfin sodium in vitro |
| Q36352937 | Efficacy of ablation at the anteroseptal line for the treatment of perimitral flutter |
| Q38119386 | Electrophysiology procedures: weighing the factors affecting choice of anesthesia |
| Q50906422 | Factors impacting complication rates for catheter ablation of atrial fibrillation from 2003 to 2015. |
| Q46077744 | Figure-of-eight suture for venous hemostasis in fully anticoagulated patients after atrial fibrillation catheter ablation |
| Q90268364 | Gender Differences in Atrial Fibrillation: A Review of Epidemiology, Management, and Outcomes |
| Q38954398 | Gender Disparities Across the Spectrum of Advanced Cardiac Therapies: Real or Imagined? |
| Q47608263 | Increased rates of atrial fibrillation recurrence following pulmonary vein isolation in overweight and obese patients |
| Q89910880 | Intracardiac Fibrinolysis and Endothelium Activation Related to Atrial Fibrillation Ablation with Different Techniques |
| Q43522735 | One size doesn't fit all: AF ablation, complications, and patients with structural heart disease |
| Q46827098 | Optimal strategies including use of newer anticoagulants for prevention of stroke and bleeding complications before, during, and after catheter ablation of atrial fibrillation and atrial flutter |
| Q28468725 | Outcome of Circumferential Pulmonary Vein Isolation for Ablation of Atrial Fibrillation: A Single Center Experience |
| Q36407198 | Outcomes of Medicare beneficiaries undergoing catheter ablation for atrial fibrillation |
| Q43528127 | Patient selection for catheter ablation of atrial fibrillation: from paroxysmal to chronic |
| Q38084254 | Percutaneous recanalization of totally occluded pulmonary veins after pulmonary vein isolation-intermediate-term follow-up |
| Q92616616 | Pericardial tamponade as a complication of invasive cardiac procedures: a review of the literature |
| Q38398014 | Periprocedural Management of New Oral Anticoagulants in Atrial Fibrillation Ablation |
| Q39234770 | Physician-controlled costs: the choice of equipment used for atrial fibrillation ablation |
| Q85639640 | Postprocedural neuropathy after atrial fibrillation ablation |
| Q37468856 | Preserving Cognitive Function in Patients with Atrial Fibrillation |
| Q46182102 | Preventing complications following catheter ablation of atrial fibrillation: is intracardiac echocardiography the answer we are seeking? |
| Q46000086 | Prevention of periprocedural ischemic stroke and management of hemorrhagic complications in atrial fibrillation ablation under continuous warfarin administration. |
| Q38036333 | Quality of life and patient-centered outcomes following atrial fibrillation ablation: short- and long-term perspectives to improving care |
| Q36537035 | Relation of morbid obesity and female gender to risk of procedural complications in patients undergoing atrial fibrillation ablation. |
| Q38790523 | Role of Intracardiac echocardiography in Atrial Fibrillation Ablation |
| Q38080752 | Role of cardiac computed tomography and cardiovascular magnetic resonance imaging in guiding management and treatment of patients with atrial fibrillation: state of the art review |
| Q30490526 | Safety and Efficacy of Under-dosing Non-vitamin K Antagonist Oral Anticoagulants in Patients Undergoing Catheter Ablation for Atrial Fibrillation |
| Q86843043 | Safety and efficacy outcomes of protamine administration for heparin reversal following cryoballoon-based pulmonary vein isolation |
| Q36124349 | Sequelae after AF ablation: Efficacy and Safety go Hand in Hand |
| Q37469058 | Sex Differences In Outcomes Of Ablation Of Atrial Fibrillation |
| Q39315683 | The effects of gender on electrical therapies for the heart: procedural considerations, results and complications: A report from the XII Congress of the Italian Association on Arrhythmology and Cardiostimulation (AIAC). |
| Q46280422 | Uninterrupted warfarin anticoagulation for atrial fibrillation ablation: too good to be true? |
| Q38131689 | Update on atrial fibrillation catheter ablation technologies and techniques |
| Q50175256 | Updated national multicenter registry on procedural safety of catheter ablation for atrial fibrillation. |
| Q38638568 | Use of intracardiac echocardiography during atrial fibrillation ablation to avoid complications |
| Q38041202 | Venice Chart international consensus document on atrial fibrillation ablation: 2011 update |
| Q42693712 | Where do we come from? Where are we going? Adverse outcomes in catheter ablation for atrial fibrillation |
Search more.